For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html This is an introductory video about cancer which encompasses various aspects of cancer. Source of the article published in description is Wikipedia. I am sharing their material. Copyright by original content developers. Link- http://en.wikipedia.org/wiki/Main_Page
Views: 45630 Shomu's Biology
Oncologists are turning to a novel form of therapy to combat cancer: retraining or reengineering the immune system to quash tumor growth. In this seminar, hear from Harvard Medical School scientists and clinicians on the latest approaches that use the body’s own defenses to fight cancer. Speakers: - Arlene Sharpe, MD, PhD - Catherine J. Wu, MD - Jerome Ritz, MD - David F. McDermott, MD Like Harvard Medical School on Facebook: https://goo.gl/4dwXyZ Follow on Twitter: https://goo.gl/GbrmQM Follow on Instagram: https://goo.gl/s1w4up Follow on LinkedIn: https://goo.gl/04vRgY Website: https://hms.harvard.edu/
Views: 9231 Harvard Medical School
Thea Tlsty, UCSF Professor of Pathology, explains the biology of cancer; that cancer arises primarily through damage to the genetic program of our cells, how this leads to uncontrolled growth and invasion, how cancer intrudes upon and destroys adjacent or distant tissues, and how the inner workings of the cancer cell function. Series: "UCSF Osher Mini Medical School for the Public" [1/2012] [Health and Medicine] [Show ID: 22574]
Views: 64449 University of California Television (UCTV)
MIT 7.013 Introductory Biology, Spring 2011 View the complete course: http://ocw.mit.edu/7-013S11 Instructor: Tyler Jacks In this lecture, Professor Jacks covers the fundamental definitions of different types of cancers, as well as their stages of progression. License: Creative Commons BY-NC-SA More information at http://ocw.mit.edu/terms More courses at http://ocw.mit.edu
Views: 37696 MIT OpenCourseWare
(Visit: http://www.uctv.tv/) Dr. Andrew Ko, UCSF Comprehensive Cancer Center, provides definitions and terms used in cancer diagnosis and treatment. He explores the process of diagnosis from biopsies to imaging and how staging is established. He also discusses the multimodality approach to treatment which typically includes surgical oncology, medical oncology and radiation oncology. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [10/2013] [Health and Medicine] [Show ID: 25630]
Views: 103052 University of California Television (UCTV)
Cancer: A Nutritional Intervention can be purchased here, http://karenhurd.com/store.html Can cancer be cornered and killed, or coaxed to life, by the foods you eat? Certainly! In this DVD nutritionist Karen Hurd presents her strategy of nutritional intervention for one of the toughest health problems of our times. Lifestyle and dietary choices can increase lifespan, decrease discomfort, and even in certain cases eliminate already-present cancer. Nutrition is even more effective to prevent onset. Learn which foods encourage cancer, and which support your immune system in the struggle against cancer. A step-by-step plan is outlined, one which has no side effects, only side benefits. Adding this DVD to your arsenal for cancer countermeasures and prevention will give you a clearer understanding of cancer's causes and corrections. Running time 1 hour, 56 minutes. © Karen R. Hurd Nutritional Practice, LLC
Views: 1173 Karen R. Hurd Nutrition
This video captures the many different levels of scientific interactions that take place during the free “Re-Thinking the Science of Cancer” seminars, that our team is sponsoring throughout the Washington DC area. The purpose of this outreach is to rapidly empower “recent-arrivers” to the field of cancer (patients, their care-givers, and young researchers) with the tools for collaborating effectively as experts—with others—in conducting their own unique cancer immunotherapy experiments. In addition, due to the question-driven format of this seminar series, the same highly-interactive, interdisciplinary and intergenerational scientific dialogue is proving to be remarkably effective in growing a brand-new set of research options that are designed to lead toward a “Cancer Free America”. Please leave a comment below or contact us on firstname.lastname@example.org, if you would like us to sponsor a free "Re-Thinking the Science of Cancer" at your university or scientific institution.
Views: 1324 Ananya Malcha
The metabolism of cancer cells is reprogrammed both by oncogene signaling and by dysergulation of metabolic enzymes. It has been proved that oncogenes are frequently altered in various cancers. A substantial proportion of oncogenic abnormalities is associated with growth signaling pathway. Recently, increasing evidence has suggested that growth signaling pathways directly control cell metabolism through the regulation of metabolic enzymes. In addition, individual metabolic enzymes have been reported to be mutated or amplified during tumor progressions. The resulting altered metabolism supports cellular proliferation and the survival but leaves cancer cells dependent on a continuous supply of nutrients.
Views: 1471 Biology and beyond
This is the introductory video for Dr. Junseong Park's presentation.
Views: 139 Biology and beyond
Seminar on Cancer systems biology by Reinhard Laubenbacher organized by BCB Lab at iastate. More information about Reinhard Laubenbacher can be found at http://www.vbi.vt.edu/faculty/personal/Reinhard_Laubenbacher and BCB Lab : http://lab.bcb.iastate.edu/.
Views: 97 bcblabseminar
KI biologist and cancer research pioneer Robert Weinberg discovered the first human oncogene and literally wrote the (text)book on cancer. His contributions and mentorship in the field have inspired multiple generations of researchers to apply their skills and talents to the ongoing fight against this deadly disease. Following his masterclass presentation about the mechanisms of metastasis, Professor Weinberg sat down with former trainee Tyler Jacks, now the director of the Koch Institute, for an intimate conversation about their shared passion for cancer research and professional journeys at MIT. This program was the second of five special with/in/sight events celebrating our fifth anniversary and highlighting the pillars of progress in MIT's interdisciplinary approach to cancer research
Views: 2642 KochInstituteMIT
Vanderbilt Medical Center's 2007 Commodore Award was presented to Pamela Martin, Lab Manager for Cancer Biology. http://www.vanderbilt.edu/myvu/news/2007/09/26/rocky-alvey-and-pamela-martin-receive-commodore-awards.47414 http://www.mc.vanderbilt.edu/
Views: 2064 ChptrHouse
Dr. Sangwon Kang is a professor at Ewha woman's university, department of life science. And he has been working on cell signaling research, mainly on the ROS and redox signaling in cells. Professor Kang will give a lecture about the new type of cancer treatment. Which use ROS and redox signaling modulation to kill cancer cells. For example, there is peroxiredoxin 2 in our body and it protects VEGFR2 by removing ROS. If we eliminate peroxiredoxin 2, VEGF signal cannot be transmitted to cancer cells and it causes damage to cells.
Views: 468 Biology and beyond
Lecture on the topic of Cancer Biology by Dr. Alok Chandra Bharti in INSPIRE Camp 2016 at RKGEC
Views: 63 RKGEC Official
Traditional cytotoxic drugs target rapidly dividing cells primarily via inhibition of cell division. For example, alkylating agents disrupt DNA base pairing, and taxane inhibits normal microtubule function. But the therapeutic efficiency of cytotoxic drugs is limited by broad toxicity to proliferating normal cells. They show low therapeutic index and narrow therapeutic window. Also, most cytotoxic anticancer drugs have to be used near their maximum tolerable doses to achieve meaningful therapeutic effects. And there are some side effects because drugs cannot target tumor cells only. That's why targeted chemotherapy came up. Targeted therapy shows higher specificity against tumor cells. It targets growth factors, signaling molecules, cell cycle proteins or regulator of angiogenesis. There are two main types of targeted therapeutics. Monoclonal antibodies are specific for extracellular target, and show modest toxicity. Small molecule inhibitors show broader specificity for intracellular targets since they can enter readily into the cells.
Views: 837 Biology and beyond
Cell-substratum adhesion is mediated by integrins, a family of transmembrane, heterodimeric, extracellular matrix receptors that are concentrated at focal adhesions. Integin engagement influences a variety of signaling pathways and regulates cell behaviors including motility, proliferation, and survival. Disturbance of normal integrin function is associated with a variety of pathologic conditions including cancer. In the first segment of my seminar, I provide a broad overview of the cancer problem for a lay audience. Advances in our understanding of cancer as a genetic disease are discussed. The influence of cell adhesion on control of cell growth is reviewed. See more at http://www.ibiology.org
Views: 24916 iBiology
Tom Laughlin discusses a new seminar series he will be giving based his book "The 6 Psychological Factors that can Lead to Cancer". This will be a four week - 1 hour per week - online seminar where attendees can ask questions and interact with Tom. If you have cancer, or have a loved one who has cancer, or are worried about getting cancer, you don't want to miss this seminar series.
Views: 12856 Tom Laughlin
Kathryn Wellen, Department of Cancer Biology, Abramson Family Cancer Research Institute University of Pennsylvania, Philadelphia - USA. "Cancer Cell Metabolic Reprogramming: Links to the Epigenome". This seminar has been recorded by ICGEB Trieste
Views: 391 Icgeb
Presented by Nuri Oh for review of Prof. Seok-gu Kang's lecture on cancer stem cell in glioblastoma multiforme
Views: 729 Biology and beyond
For additional information visit http://www.cancerquest.org/frank-slack-interview. Dr. Frank Slack is Professor of Molecular, Cellular & Developmental Biology at Yale University. Dr. Slack's research is directed at understanding the role of microRNAs in cancer, both as possible treatments and as potential targets of therapy. MicroRNAs are small RNA molecules that are normally found in cells. They are able to control the activity of genes and alter the translation of messenger RNAs (mRNAs). The microRNAs present in a normal cell are not exactly the same as those in a cancer cell and that difference could be critical for many cancer types. In this interview, Dr Slack discusses the background to his interest in cancer biology. To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org.
Views: 246 CancerQuest
For more than 10 years, Lothar Hirneise has traveled the world looking for the most successful cancer therapies, He has been the president of Cancer 21 since 1997, an organisation for research and documentation of holistic cancer therapies with approximately. 2.000 members worldwide. He is the author of the bestseller book: Chemotherapy heals cancer and the world is flat and director of the 3E-center in Germany. For many years he is teaching worldwide the 3E program, which is based on the analysis of case histories of thousands of people who survived late stage cancer. Learn why so many people die of cancer, and why so many others do not. http://www.hirneise.com/index.html
Views: 2944 CIS PTA
This is a seminar to a small group in LOROS hospice Leicester on distress+depression in cancer. Thanks to the audience for some interesting questions! Prof Mitchell covers a lots of topics under the following key messages: 1:30 KM1 Unmet needs 18:20 KM2 Depression 28:55 KM3 Eveyones responsibility 37:40 KM4 6th vital sign 50:05 KM5 Implementation 1:00:40 KM6 Screening evidence 1:04:00 KM7 Spouses 1:06:48 KM8 Outcomes 1:17:23 KM9 Resources 1:22:15 KM10 New developments also look out for 18:50 Validity of somatic symptoms of depression 26:00 Depressive symptoms in palliative stages 30:40 GP enquiry about depression 33:30 Clinician detection accuracy (sens spec) 36:20 GAD-DSM vs GAD7 45:30 PHQ2 / Simple QQ for depression 50:50 Barriers to distress screening 54:35 Desire for psychosocial help 1:07:20 Psychological influence on survival 1:19:10 Acceptability of treatments 1:24:00 Cancerstories innovation ---------------------------------------------------------------------------------------------------------------------------------------------------- Resolution: 1080p Permissions: Email email@example.com Twitter: https://www.twitter.com/cancer_stories Facebook: https://www.facebook.com/cancerstoriesonline ----------------------------------------------------------------------------------------------------------------------------------------------------
Views: 594 MyCancerStory
ABOUT THE CONFERENCE:- The ICNDTC 2018: International Conference on Nanomedicine in Diagnostics &Theranostics in Cancer aims to bring together leading academic scientists, researchers and scholars to exchange and share their experiences and research results on all aspects of Cancer Biology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Cancer Biology and Nanomedicine. IMPORTANT DATES AND TIMES:- Online Registration Starts: January 25th, 2018 Abstracts/Full Paper Submission Deadline: February 25th, 2018 Notification of Acceptance/Rejection: March 1st, 2018 Last date Online Registration (Without paper): March 3rd, 2018 Spot Registration (8:30am-1:30 pm(No paper)): March 9th, 2018 Conference Dates: March 9-11th, 2018 Oral Presentation(12:00-1:30 pm; 3:00-5:00pm): March 10th, 2018 Poster Presentation (3:00pm-5:00pm): March 10th, 2018 VENUE:- M.K.C.G Auditorium, Utkal University, Vani-Vihar, Bhubaneswar, Odisha, India -04 Distance from Railway Station: About 3 Km Distance from Biju Patnaik International Airport : About 5 Km Distance from Puri Jagannath Dham - 60 Km Distance from Konark - 60 Km ORGANISED BY:- UNIVERSITY DEPARTMENT OF PHARMACEUTICAL SCIENCES UTKAL UNIVERSITY, VANI VIHAR BHUBANESWAR For details please Contact: Dr. Debasish Pradhan Organising Secretary- UDPS PHARMACON 2018 UDPS, Utkal University, Vani-Vihar, Bhubaneswar, Odisha, India. Phone: - 9853812499, 9776311737 Email: - firstname.lastname@example.org, email@example.com Website: - www.udpspharmacon.org THANKING YOU.............
Views: 643 UDPS Pharmacon
Life Sciences Outreach Lecture Series at Harvard University - The Biology of Cancer New cancer treatments are being evaluated that take advantage of a better understanding of the biology of cancer cell growth. Dr. Burstein will focus on "targeted" therapies for cancer and new drugs that are changing our treatment strategies. The use of hormonal therapies, growth factor receptor inhibitors, and angiogenesis inhibitors will be highlighted. Videos produced by Leigh Stimolo, 2003
Views: 243 Leigh Stimolo
Data managers at two NCI-designated cancer research facilities are using online data capture to facilitate groundbreaking research. Carol Lowenstein of Dana-Farber Cancer Institute discusses the CanSeq Initiative, which seeks to "develop a model for the integration of germline and somatic genome sequencing into the care of cancer patients." The study is made up of three sub-projects -- focused on lab, clinical and social/behavioral aspects -- and involves three types of subjects (physicians, patients, and committee members) with multiple study arms. Scott Sutherland and David Rogers of Fred Hutchinson Cancer Research Center discuss the double data entry scripts and call center management software they have developed to work in conjunction with DatStat software for data capture and workflow management. They also highlight three current studies: TALK Smoking Cessation Study, Sjogren's Syndrome Biomarkers Study, and PLAT01 Cellular Immunotherapy Study. These studies require varying combinations of workflow management, multi-mode surveys, CRFs and eCRFs, audit trails, and adverse event tracking.
Views: 174 DatStat
this ,seminar was , conducted in NOVA College Of pharmacy , its very imp.
Views: 355 Let’s be International
For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html Source of all articles published in description is Wikipedia. Thanks to original content developers. Link- http://en.wikipedia.org/wiki/Main_Page Cancer immunology is the study of interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens is of particular interest in the field as knowledge gained drives the development of new vaccines and antibody therapies. For instance in 2007, Ohtani published a paper finding tumour infiltrating lymphocytes to be quite significant in human colorectal cancer. The host was given a better chance at survival if the cancer tissue showed infiltration of inflammatory cells, in particular those prompting lymphocytic reactions. The results yielded suggest some extent of anti-tumour immunity is present in colorectal cancers in humans. Over the past 10 years there has been notable progress and an accumulation of scientific evidence for the concept of cancer immunosurveillance and immunoediting based on (i) protection against development of spontaneous and chemically-induced tumors in animal systems and (ii) identification of targets for immune recognition of human cancer. Cancer immunosurveillance is a theory formulated in 1957 by Burnet and Thomas, who proposed that lymphocytes act as sentinels in recognizing and eliminating continuously arising, nascent transformed cells. Cancer immunosurveillance appears to be an important host protection process that decreases cancer rates through inhibition of carcinogenesis and maintaining of regular cellular homeostasis. It has also been suggested that immunosurveillance primarily functions as a component of a more general process of cancer immunoediting.
Views: 21042 Shomu's Biology
Endometrial cancer affects 48,000 women per year in the United States. For patients with tumors greater than two centimeters in diameter, the effected organ(s) and lymph nodes may be surgically removed. Yet post-surgery analysis shows that only 22 percent of patients had metastasis, meaning 78 percent of these surgeries may have been unnecessary. How can doctors predict which patients need surgery? Mathukumalli Vidyasagar discusses how new computational algorithms from National Science Foundation-sponsored research have been successfully applied to cancer data in a clinical translational setting. One such algorithm can predict the time to tumor recurrence in ovarian cancer patients and has been shown to predict the efficacy levels of several natural product compounds on lung cancer cells. This cutting-edge research in machine learning and computational algorithms has the potential to transform clinical practice and personalized cancer treatment therapies. Vidyasagar is the Cecil & Ida Green Chair in Systems Biology Science in the Erik Jonsson School of Engineering & Computer Science at the University of Texas at Dallas. He has received a number of awards in recognition of his research contributions, including Fellowship in The Royal Society, the IEEE Control Systems (Field) Award, and the Rufus Oldenburger Medal of ASME.
Views: 1746 National Science Foundation
The end of 2011 marked the 40-year anniversary of President Nixon declaring the War on Cancer. Though a cure has not yet been discovered, the understanding of genetics is revolutionizing cancer research and improving the ways in which we can battle one of medicine's most challenging diseases. At this April 3, 2012, seminar, Harvard researchers will discuss how far we have come and where the field is heading in revealing the causes of cancer and our potential to develop transformative therapies. Learn more about the Longwood Seminars by visiting hms.harvard.edu/public/longwood.
Views: 4452 Harvard Medical School
Date: Monday, September 10, 2012 Location: McMaster University, Hamilton, ON Dr. Rosalyn Juergens, Assistant Professor, Department of Oncology, McMaster University; Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute Clinical presentation with patient interview Learning Objectives: To discuss pathological relevance of immune infiltrates in tumors To illustrate the history of immune-directed therapy in cancer treatment To review the currently available immunotherapies in solid tumours To identify challenges that remain to be overcome
Views: 817 McMaster University Health Sciences
Seminar on Cancer and modern diseases by Dr.Mohandas - Organized by National Organization For Health And Palliative Care www.indianpalliative.org National Organization For Health And Palliative Care Helpline & Free Consultation: Call +91 9388164646 (Cancer, Piles, Stroke or any major diseases)
Views: 25 HelloWeb Palakkad